Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NOURLIE IBUYAT CARLOS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1588244164
CMS profile
10643608
Location
TULARE, CA

General Payments · PY2021–2024

$4,014.49

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,446.91

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $2,125.00 1
Lilly USA, LLC $187.11 6
Amgen Inc. $46.62 3
MannKind Corporation $31.71 2
Novo Nordisk AS $21.09 1
NOVARTIS PHARMACEUTICALS CORPORATION $20.07 1
Boehringer Ingelheim Pharmaceuticals, Inc. $15.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $234.99 2
PY2022 $18.85 1
PY2023 $1,313.74 64
PY2024 $2,446.91 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.04 01/12/2024 Food and Beverage Undisputed 01/23/2026 1117521019 CMS
Amgen Inc. $13.26 01/18/2024 Food and Beverage Undisputed 01/23/2026 1117521021 CMS
Amgen Inc. $16.32 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117521023 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.31 11/13/2024 Food and Beverage Undisputed 01/23/2026 1118069156 CMS
Lilly USA, LLC $27.48 01/30/2024 Food and Beverage Undisputed 01/23/2026 1135915539 CMS
Lilly USA, LLC $25.30 04/08/2024 Food and Beverage Undisputed 01/23/2026 1135915143 CMS
Lilly USA, LLC $109.05 05/02/2024 Food and Beverage Undisputed 01/23/2026 1135915537 CMS
Lilly USA, LLC $13.83 07/10/2024 Food and Beverage Undisputed 01/23/2026 1135915541 CMS
Lilly USA, LLC $6.76 07/24/2024 Food and Beverage Undisputed 01/23/2026 1135938434 CMS
Lilly USA, LLC $4.69 10/01/2024 Food and Beverage Undisputed 01/23/2026 1135852368 CMS
Mannkind Corporation $16.12 04/01/2024 Food and Beverage Undisputed 01/23/2026 1145852789 CMS
Mannkind Corporation $15.59 05/14/2024 Food and Beverage Undisputed 01/23/2026 1145852791 CMS
Medtronic, Inc. $2,125.00 05/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1112062522 CMS
Novartis Pharmaceuticals Corporation $20.07 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086759397 CMS
Novo Nordisk Inc $21.09 07/17/2024 Food and Beverage Undisputed 01/23/2026 1100529755 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.